peptidas
catalys
hydrolysi
peptid
bond
enzym
wide
distribut
natur
involv
wide
varieti
biolog
peptidas
group
accord
pattern
proteolysi
either
endo
exopeptidas
exopeptidas
catalys
remov
amino
acid
short
peptid
end
polypeptid
chain
wherea
endopeptidas
cleav
peptid
bond
nontermin
amino
acid
accord
intern
union
biochemistri
molecular
biolog
iubmb
nomenclatur
exopeptidas
divid
aminopeptidas
dipeptidas
dipeptidylpeptidas
tripeptidylpeptidas
carboxypeptidas
omega
peptidas
dipeptidyl
peptidas
iv
dpp
iv
ec
homodimer
serin
peptidas
subunit
consist
approxim
amino
acid
classifi
clan
sc
famili
merop
data
enzym
preferenti
cleav
substrat
peptid
pro
ala
penultim
posit
peptid
proala
dpp
iv
isol
mammal
dpp
iv
respons
degrad
incretin
play
major
role
glucos
metabol
thu
dpp
iv
wellknown
target
new
class
oral
mammalian
dpp
iv
also
identifi
adenosin
deaminas
bind
protein
adabp
tcell
activ
antigen
sever
review
structur
function
studi
mammalian
dpp
iv
relat
enzym
contrast
bacteri
dpp
iv
paper
design
bacteri
dpp
iv
dap
iv
play
import
nutrit
role
asaccharolyt
bacteria
utilis
protein
peptid
energi
sourc
cooper
dap
iv
gene
found
mani
pathogen
bacteria
porphyromona
gingivali
caus
periodont
stenotrophomona
maltophilia
caus
opportunist
infect
structur
inform
bacteri
dap
iv
would
assist
develop
select
inhibitor
dap
iv
pathogen
bacteria
crystal
structur
analys
mammalian
dpp
iv
reveal
enzym
homodim
dimer
dimer
pig
enzym
subunit
compris
ctermin
hydrolas
domain
encompass
enzymat
activ
site
ntermin
eightblad
conserv
doubleglu
number
human
enzym
form
salt
bridg
nterminu
residu
peptid
substrat
doubleglu
motif
locat
short
helix
insert
blade
domain
doubleglu
motif
also
exist
fibroblast
activ
protein
fap
dpp
ivfamili
share
approxim
sequenc
ident
dpp
iv
exhibit
dpp
ivlik
side
chain
locat
blade
domain
involv
recognit
carbonyl
group
peptid
pocket
smaller
side
chain
pro
ala
substrat
form
hydrophob
aromat
amino
acid
hydrolas
domain
leav
space
larg
substitu
thu
crystal
structur
mammalian
dpp
iv
complex
peptid
substratesproduct
report
crystal
structur
bacteri
dap
iv
complex
either
inhibitor
reaction
intermedi
yet
report
first
bacteri
dap
iv
structur
ligandfre
dap
iv
maltophilia
smdap
iv
although
overal
structur
smdap
iv
similar
mammalian
dpp
iv
insert
delet
found
around
activ
site
exampl
involv
recognit
substrat
carbonyl
group
mammalian
dpp
iv
miss
smdap
iv
absenc
crystal
structur
bacteri
dap
iv
complex
inhibitor
reaction
intermedi
complet
structur
understand
dap
ivsubstr
interact
thu
far
imposs
knowledg
import
guid
structurebas
design
novel
select
inhibitor
pathogen
dap
iv
structur
analysi
bacteri
dap
iv
complex
inhibitor
clearli
broad
interest
recent
crystal
structur
dpp
iv
porphyromona
gingivali
pgdpp
iv
ligandfre
form
resolut
unexpectedli
overal
structur
substratebind
site
pgdpp
iv
quit
similar
human
dpp
iv
rather
smdap
iv
human
dpp
iv
conserv
pgdpp
iv
indic
dpp
iv
categoris
two
group
human
dpp
ivtyp
dpp
iv
smdap
ivtyp
dap
iv
pgdpp
iv
belong
human
dpp
iv
group
therefor
design
dpp
iv
p
gingivali
pgdpp
iv
rather
pgdap
iv
report
crystal
structur
dap
iv
pseudoxanthomona
mexicana
pmdap
iv
free
form
complex
two
dipeptid
lyspro
ilepro
well
nonpeptidyl
inhibitor
resolut
respect
overal
structur
pmdap
iv
clearli
similar
smdap
iv
differ
human
dpp
iv
sever
respect
dipeptid
complex
show
acylenzym
intermedi
activ
site
pmdap
iv
wherea
tetrahedr
intermedi
report
mammalian
dpp
activ
site
arg
residu
human
dpp
iv
help
stabilis
tetrahedr
intermedi
mammalian
dpp
interact
carbonyl
group
residu
wherea
structur
correspond
arg
residu
bacteri
dap
iv
pmdap
iv
play
role
observ
provid
new
insight
substrat
recognit
mechan
bacteri
dap
iv
pmdap
iv
enzym
form
homodim
subunit
consist
residu
molecular
weight
approxim
kda
fig
ntermin
region
pmdap
iv
typic
signal
sequenc
gramneg
bacteria
henc
pmdap
iv
exist
solubl
form
mammalian
dpp
iv
fap
type
ii
transmembran
crystal
structur
pmdap
iv
ligandfre
form
complex
dipeptid
lyspro
ilepro
nonpeptidyl
inhibitor
determin
resolut
respect
tabl
repres
electron
densiti
map
bound
peptid
inhibitor
shown
figur
electron
densiti
side
chain
ly
ile
poorer
residu
coval
attach
atom
figur
consist
result
refin
temperatur
factor
bound
ligand
atom
higher
flexibl
group
away
acylintermedi
bond
also
true
inhibitor
complex
figur
present
crystal
structur
analysi
ligandfre
pmdap
iv
asymmetr
unit
compris
two
dimer
pmdap
iv
dimeris
also
observ
crystal
structur
mammalian
dpp
protrud
antiparallel
dimeris
interfac
report
mammalian
dpp
iv
also
observ
pmdap
iv
type
intersubunit
interact
found
among
sever
crystal
form
pmdap
iv
tabl
indic
dimer
format
natur
state
pmdap
iv
protom
pmdap
iv
consist
two
domain
separ
deep
cleft
fig
one
domain
contain
hydrolas
fold
harbour
asphiss
catalyt
triad
respons
catalysi
second
domain
regulatori
domain
necessari
exopeptidas
activ
topolog
diagram
pmdap
iv
protom
shown
figur
catalyt
domain
includ
residu
form
hydrolas
fold
compris
central
eightstrand
sandwich
thirteen
hydrolas
fold
characterist
clan
sc
prolyl
oligopeptidas
famili
carboxypeptidas
famili
xaapro
dipeptidyl
peptidas
famili
proxaa
carboxypeptidas
famili
prolyl
aminopeptidas
famili
catalyt
domain
human
dpp
iv
superimpos
onto
pmdap
iv
fig
serin
peptidas
catalyt
pmdap
iv
human
dpp
iv
almost
complet
superimpos
root
mean
squar
rm
deviat
two
structur
structur
equival
atom
sequenc
ident
region
similarli
rm
deviat
catalyt
domain
pmdap
iv
smdap
iv
structur
equival
atom
sequenc
ident
region
domain
form
funnelshap
structur
compris
eight
blade
compris
four
antiparallel
except
blade
fig
contain
two
addit
compon
one
short
helix
first
second
strand
blade
helix
contain
doubleglu
motif
form
salt
bridg
nterminu
peptid
substrat
fig
addit
compon
blade
protrud
antiparallel
second
third
strand
blade
figur
antiparallel
act
dimeris
interfac
fig
hairpin
loop
second
third
strand
blade
contain
human
dpp
iv
interact
carbonyl
group
substrat
replac
short
turn
pmdap
iv
fig
interestingli
howev
side
chain
locat
blade
pmdap
iv
disord
ligandfre
form
well
defin
peptideinhibitor
complex
describ
later
appear
play
role
equival
human
dpp
iv
fig
interdomain
contact
catalyt
domain
observ
blade
domain
catalyt
domain
blade
domain
less
contact
catalyt
domain
fig
appear
flexibl
blade
rm
deviat
domain
pmdap
iv
human
dpp
iv
structur
equival
atom
sequenc
ident
region
rm
deviat
domain
pmdap
iv
smdap
iv
structur
equival
atom
sequenc
ident
region
thu
structur
domain
pmdap
iv
smdap
iv
somewhat
differ
human
enzym
comparison
crystal
structur
ligandfre
pmdap
iv
dipeptideinhibitorbound
form
pmdap
iv
show
larg
cleft
catalyt
domain
rel
close
peptideinhibitorbound
form
fig
larger
conform
differ
observ
mainli
blade
region
protrud
antiparallel
second
third
strand
blade
close
conform
observ
crystallograph
independ
subunit
dipeptideinhibitorbound
complex
crystal
asymmetr
unit
dipeptid
inhibitor
complex
crystal
contain
two
one
dimer
pmdap
iv
respect
tabl
furthermor
disord
loop
region
ligandfre
form
residu
contain
fig
well
defin
form
short
helix
dipeptideinhibitorbound
complex
figur
interestingli
one
four
subunit
asymmetr
unit
ligandfre
form
exhibit
rel
close
form
similar
observ
dipeptideinhibitorbound
form
disord
loop
region
residu
well
defin
dipeptid
lyspro
complex
obtain
cocrystallis
pmdap
iv
tripeptid
lysprotyr
clear
continu
electron
densiti
observ
first
two
residu
tripeptid
figur
clear
electron
densiti
observ
last
residu
tyr
pmdap
iv
enzym
reaction
occur
solut
use
crystallis
lysprotyr
tripeptid
act
substrat
reaction
product
ntermin
lyspro
ctermin
tyr
ntermin
product
lyspro
remain
activ
site
ctermin
product
tyr
dissoci
activ
site
interestingli
observ
tripeptid
cleav
remain
trap
acylenzym
intermedi
atom
found
close
contact
carbonyl
carbon
scissil
bond
explor
observ
ntermin
dipeptid
product
trap
acylenzym
intermedi
dipeptid
atom
omit
model
structur
refin
result
omit
electron
densiti
map
show
continu
electron
densiti
atom
carbonyl
carbon
scissil
bond
figur
asymmetr
unit
compos
four
independ
pmdap
iv
subunit
three
four
subunit
dipeptid
trap
acylenzym
intermedi
remain
subunit
hydrolys
dipeptid
product
observ
figur
similarli
cocrystallis
pmdap
iv
tripeptid
ileproil
wellknown
peptidyl
dpp
iv
inhibitor
diprotin
result
dipeptid
ilepro
complex
trap
acylenzym
intermedi
figur
ilepro
complex
acylenzym
intermedi
observ
four
subunit
asymmetr
unit
dipeptid
lyspro
ilepro
complex
structur
clearli
show
molecular
basi
peptid
recognit
mechan
pmdap
iv
simplic
follow
descript
refer
primarili
subunit
structur
lyspro
complex
pmdap
iv
bound
dipeptid
found
interdomain
cleft
fig
pmdap
iv
hydrolys
peptid
nterminu
oligopeptid
cleav
dipeptid
unit
second
residu
pro
ala
act
dipeptidyl
aminopeptidas
pmdap
iv
must
fix
nterminu
substrat
peptid
posit
task
perform
primarili
side
chain
doubleglu
motif
form
part
short
helix
first
second
strand
blade
domain
doubleglu
motif
form
salt
bridg
nterminu
bound
dipeptid
addit
side
chain
locat
blade
domain
form
hydrogen
bond
carbonyl
group
residu
also
form
salt
bridg
side
chain
side
chain
also
form
hydrogen
bond
carbonyl
group
residu
ligandfre
form
pmdap
iv
residu
locat
blade
domain
disord
correspond
region
smdap
iv
also
dipeptid
complex
pmdap
iv
electron
densiti
residu
well
defin
interpret
short
helix
figur
pro
residu
accommod
pocket
compris
side
chain
side
chain
ly
residu
less
interact
pmdap
iv
surround
water
molecul
activ
site
cleft
carbonyl
oxygen
residu
accommod
oxyanion
hole
stabilis
hydrogen
bond
mainchain
imino
group
sidechain
oh
group
similarli
import
role
oxyanion
hole
compris
mainchain
nh
sidechain
oh
catalyt
mechan
human
dpp
iv
addit
dipeptid
complex
describ
nonpeptidyl
inhibitor
complex
also
show
structur
featur
activ
site
pmdap
iv
fig
inhibitor
use
studi
hydroxymethyl
cyclopentyl
amino
acetyl
known
achir
inhibitor
mammalian
dpp
commerci
avail
hydrochlorid
salt
figur
unbias
omit
electron
densiti
map
figur
suggest
one
nitril
group
inhibitor
attack
form
coval
bond
similar
coval
bond
also
report
crystal
structur
analysi
human
dpp
iv
complex
imid
format
confirm
tripl
bond
moieti
nitril
group
stack
side
chain
pyrrolidin
ring
accommod
pocket
inhibitor
moieti
correspond
peptid
backbon
recognis
interact
side
chain
secondari
amin
group
side
chain
carbonyl
group
cyclopentan
ring
inhibitor
less
contact
activ
site
find
consist
poorer
electron
densiti
observ
cyclopentan
moieti
compar
pyrrolidin
ring
moieti
figur
test
role
substrat
bind
pmdap
iv
replac
arginin
residu
alanin
lysin
test
enzymat
activ
mutant
protein
synthet
substrat
glypromca
tabl
mutat
ala
result
signific
loss
activ
approxim
wildtyp
enzym
activ
result
indic
pmdap
iv
play
import
role
recognit
substrat
peptid
interestingli
mutat
ly
also
result
moder
decreas
activ
synthet
substrat
approxim
wildtyp
enzym
activ
result
indic
posit
charg
strict
bind
mode
provid
side
chain
posit
essenti
interact
carbonyl
group
substrat
peptid
side
chain
observ
wildtyp
enzym
fig
examin
whether
signific
differ
substrat
recognit
mechan
pmdap
iv
mammalian
dpp
iv
inhibitori
activ
dpp
iv
inhibitor
also
known
gliptin
figur
pmdap
iv
human
dpp
iv
evalu
tabl
gliptin
categoris
three
class
accord
bind
class
gliptin
bind
subsit
class
bind
subsit
class
bind
subsit
result
show
class
gliptin
linagliptin
trelagliptin
significantli
weaker
inhibitori
activ
pmdap
iv
class
gliptin
tabl
contrast
class
gliptin
inhibitori
activ
human
dpp
iv
compar
stronger
class
gliptin
studi
solv
crystal
structur
bacteri
dpp
iv
pmdap
iv
specif
recognis
proala
residu
posit
substrat
peptid
better
understand
substrat
recognit
mechan
bacteri
dap
iv
solv
structur
pmdap
iv
presenc
peptid
inhibitor
peptid
complex
doubleglu
motif
form
salt
bridg
nterminu
bound
dipeptid
interact
essenti
exopeptidas
activ
pmdap
iv
interestingli
fap
dipeptidyl
peptidas
activ
endopeptidas
crystal
structur
human
fap
reveal
one
major
differ
vicin
doubleglu
motif
fap
within
activ
site
enzym
fap
instead
human
dpp
iv
reduc
acid
nterminu
bind
pocket
chang
could
explain
lower
affin
ntermin
amin
endopeptidas
activ
pmdap
iv
correspond
residu
fig
consist
biochem
data
pmdap
iv
endopeptidas
complex
structur
pmdap
iv
also
reveal
side
chain
locat
blade
domain
form
hydrogen
bond
carbonyl
group
residu
substrat
peptid
form
salt
bridg
side
chain
ligandfre
form
pmdap
iv
smdap
loop
blade
domain
contain
pmdap
iv
disord
disord
loop
region
ligandfre
form
residu
contain
fig
well
defin
form
short
helix
dipeptideinhibitorbound
complex
correspond
region
mammalian
dpp
iv
replac
short
turn
involv
substrat
recognit
sitedirect
mutagenesi
studi
pmdap
iv
tabl
indic
arg
side
chain
essenti
substrat
recognit
fix
side
chain
one
side
chain
doubleglu
motif
residu
blade
domain
contain
pmdap
iv
highli
conserv
smdap
iv
figur
contrast
region
human
dpp
iv
conserv
p
gingivali
dpp
iv
figur
thu
dpp
iv
categoris
two
group
human
dpp
ivtyp
dpp
iv
smdap
ivtyp
dap
iv
phylogenet
analysi
sever
dpp
iv
support
notion
figur
shown
figur
pmdap
iv
smdap
iv
belong
cluster
wherea
pgdpp
iv
belong
bacteri
cluster
distinct
smdap
ivtyp
cluster
relat
vertebr
dpp
iv
cluster
interestingli
phylogenet
analysi
reveal
human
dipeptidyl
peptidas
human
dipeptidyl
peptidas
ubiquit
express
solubl
dpp
ivlik
approxim
amino
acid
sequenc
ident
human
dpp
iv
belong
bacteri
dap
iv
cluster
rather
vertebr
dpp
iv
cluster
hand
anoth
dpp
ivlik
enzym
human
approxim
amino
acid
sequenc
ident
human
dpp
iv
belong
vertebr
dpp
iv
cluster
confirm
result
phylogenet
analysi
fap
compar
amino
acid
sequenc
pmdap
iv
four
dpp
ivfamili
fig
clear
region
pmdap
iv
conserv
human
human
wherea
region
human
dpp
iv
conserv
human
fap
thu
may
said
pmdap
iv
bacteri
though
dap
iv
yet
identifi
p
mexicana
anoth
interest
structur
differ
human
dpp
iv
pmdap
iv
human
dpp
iv
promin
expos
loop
domain
pmdap
iv
fig
particular
insert
fourth
strand
specif
found
human
dpp
iv
fig
involv
interact
protein
adenosin
bat
coronaviru
receptorbind
catalyt
mechan
serin
peptidas
involv
two
tetrahedr
figur
show
possibl
catalyt
mechan
pmdap
iv
essenti
ident
dpp
except
role
arginin
side
chain
describ
later
oxyanioncontain
tetrahedr
intermedi
fig
stage
stabilis
backbon
nh
group
sidechain
oh
group
gener
posit
charg
pocket
known
oxyanion
present
crystal
structur
analys
acylenzym
intermedi
fig
stage
obtain
cocrystallis
pmdap
iv
tripeptid
lysprotyr
ntermin
product
lyspro
remain
activ
site
stabilis
salt
bridg
doubleglu
motif
final
ctermin
product
tyr
dissoci
activ
site
hydrolys
dipeptid
product
fig
stage
also
observ
figur
seen
figur
activ
site
acylintermedi
complex
pmdap
iv
enough
space
near
accommod
nucleophil
water
although
could
identifi
present
crystal
structur
analys
interestingli
similar
acylenzym
intermedi
observ
pmdap
iv
cocrystallis
tripeptid
ileproil
wellknown
peptidyl
dpp
iv
inhibitor
diprotin
result
dipeptid
ilepro
complex
figur
complex
human
dpp
iv
inhibitor
diprotin
tetrahedr
intermedi
fig
stage
rather
acylenzym
intermedi
bound
diprotin
molecul
stabilis
hydrophob
interact
larg
network
salt
bridg
hydrogen
bond
nterminu
tripeptid
interact
doubleglu
motif
cterminu
interact
human
dpp
iv
notabl
noncoval
diprotin
complex
also
report
human
dpp
case
interact
carbonyl
oxygen
residu
respons
fix
conform
diprotin
molecul
thu
role
consist
diprotin
complex
human
dpp
iv
similar
tetrahedr
intermedi
report
human
dpp
iv
complex
decapeptid
tnpi
complex
similar
network
salt
bridg
hydrogen
bond
observ
carbonyl
group
third
residu
stabilis
argo
c
interact
present
tripeptid
longer
peptid
would
prevent
releas
leav
residu
stabilis
observ
tetrahedr
intermedi
tripeptid
longer
peptid
neg
charg
carboxyl
carbonyl
group
electrostat
stabilis
posit
charg
catalyt
therebi
prevent
transfer
proton
nitrogen
atom
releas
group
nterminu
residu
consequ
c
bond
cleav
residu
leav
activ
site
mammalian
dpp
interestingli
structur
similar
arginin
residu
pmdap
iv
interact
carbonyl
group
residu
bound
peptid
therefor
play
role
stabilis
acylenzym
intermedi
fig
stage
observ
studi
rather
stabil
tetrahedr
intermedi
fig
stage
observ
human
dpp
iv
examin
whether
pmdap
iv
involv
recognit
test
inhibitori
activ
diprotin
enzymat
activ
pmdap
iv
tabl
result
show
diprotin
good
inhibitor
pmdap
iv
compar
stronger
inhibitori
activ
diprotin
pmdap
iv
compar
human
dpp
iv
tabl
indic
poorer
interact
residu
diprotin
pmdap
iv
affect
inhibitori
activ
diprotin
thu
crystallograph
observ
coval
bond
interact
acylenzym
intermedi
observ
pmdap
iv
cocrystallis
diprotin
studi
figur
tetrahedr
intermedi
observ
mammalian
dpp
iv
cocrystallis
diprotin
essenti
structur
factor
relat
inhibitori
activ
diprotin
two
possibl
rout
activ
site
dpp
iv
tunnel
domain
side
open
catalyt
domain
mammalian
dpp
iv
propos
tunnel
side
open
respect
provid
substrat
access
product
releas
activ
site
dpp
howev
crystal
structur
analys
human
dpp
iv
complex
suggest
side
open
entranc
activ
site
bound
peptid
orient
nterminu
face
activ
site
cterminu
face
side
open
md
simul
demonstr
side
open
like
pathway
product
releas
tunnel
base
quantit
comparison
forc
work
togeth
potenti
mean
forc
two
thu
sidein
sideout
model
plausibl
propellerin
sideout
model
mammalian
dpp
iv
crystal
structur
analysi
pmdap
iv
conform
differ
observ
dipeptid
inhibitorbound
form
compar
ligandfre
form
fig
observ
clearli
differ
crystal
structur
analys
mammalian
dpp
iv
largescal
conform
differ
yet
report
note
open
form
microbi
prolyl
oligopeptidas
pop
share
certain
sequenc
homolog
dpp
iv
larg
substrat
could
enter
side
open
howev
thought
pop
possess
dpp
ivequival
side
open
thu
intern
caviti
seem
access
via
structur
obtain
provid
insight
possibl
rout
substrat
bind
product
releas
pmdap
iv
regard
substrat
access
rout
tunnel
unlik
substrat
access
activ
site
tunnel
peptid
must
adopt
energet
unfavour
umbrella
handleshap
conform
nterminu
face
tip
handl
toward
doubleglu
motif
cterminu
face
bodi
handl
tunnel
fig
contrast
access
rout
side
open
provid
impedi
product
releas
egress
side
open
appear
easi
exclud
tunnel
rout
dipeptid
inhibitorbound
form
pmdap
iv
interdomain
cleft
pmdap
iv
rel
close
bound
peptideinhibitor
buri
activ
site
expos
solvent
fig
reaction
product
exit
activ
site
without
closedtoopen
conform
chang
thu
product
may
exit
activ
site
via
tunnel
without
conform
chang
ii
via
side
open
conform
chang
final
although
sidein
sideout
model
highli
possibl
sidein
propellerout
model
exclud
bacteri
dap
iv
notabl
one
four
subunit
molecul
b
asymmetr
unit
ligandfre
crystal
pmdap
iv
show
rel
close
conform
observ
dipeptideinhibitorbound
complex
rm
deviat
molecul
b
ligandfre
pmdap
iv
molecul
lyspro
complex
pmdap
iv
atom
disord
loop
region
molecul
c
ligandfre
form
residu
contain
well
defin
molecul
b
residu
form
short
helix
observ
dipeptideinhibitor
complex
conform
around
short
helix
molecul
b
ligandfre
form
molecul
lyspro
complex
quit
similar
figur
wherea
rel
flexibl
residu
estim
temperatur
factor
significantli
higher
molecul
b
ligandfre
form
averag
bfactor
whole
molecul
vs
residu
vs
molecul
b
ligandfre
form
vs
molecul
lyspro
complex
observ
indic
opentoclos
conform
chang
protom
pmdap
iv
occur
without
ligand
bind
mechan
conform
select
would
exist
substratebind
stage
pmdap
iv
clarifi
differ
activ
site
architectur
pmdap
iv
mammalian
dpp
iv
compar
inhibitori
activ
three
class
figur
pmdap
iv
human
dpp
iv
tabl
gener
inhibitori
activ
gliptin
human
dpp
iv
order
nm
overwhelmingli
high
compar
pmdap
iv
order
unnatur
structur
gliptin
optimis
bind
human
dpp
iv
bacteri
dap
iv
differ
might
partli
due
less
hydrophob
properti
bottom
subsit
pmdap
iv
human
dpp
iv
replac
respect
pmdap
iv
figur
result
show
class
gliptin
significantli
weaker
inhibitori
activ
pmdap
iv
class
class
gliptin
note
omarigliptin
exhibit
lower
inhibitori
activ
pmdap
iv
compar
class
gliptin
explain
structur
featur
omarigliptin
shown
figur
omarigliptin
less
rotat
bond
class
gliptin
therefor
omarigliptin
fit
well
activ
site
pmdap
iv
gliptin
sensit
pmdap
iv
explain
structur
compar
subsit
pmdap
iv
human
dpp
iv
complex
fig
compar
human
dpp
iv
residu
pmdap
iv
protrud
subsit
fig
caus
narrow
site
thu
region
would
hinder
bind
class
gliptin
pmdap
iv
fig
contrast
subsit
subsit
pmdap
iv
clearli
larger
human
dpp
iv
space
occupi
residu
human
dpp
iv
occupi
protein
residu
pmdap
iv
fig
indic
inhibitor
occupi
space
might
select
inhibitor
bacteri
dap
iv
fig
structur
comparison
pgdpp
iv
human
dpp
iv
also
reveal
subsit
pgdpp
iv
larger
human
dpp
sitagliptin
class
gliptin
wellknown
highli
select
dpp
iv
crystal
structur
analys
human
dpp
iv
complex
class
reveal
import
interact
gliptin
human
dpp
iv
strict
dpp
iv
select
dpp
ivfamili
enzym
fap
hydrophob
pipi
interact
side
chain
inhibitor
site
utilis
extens
subsit
human
dpp
iv
class
gliptin
increas
inhibitori
activ
human
dpp
iv
also
select
dpp
ivfamili
enzym
specif
pmdap
iv
probabl
suffici
hydrophob
interact
class
inhibitor
site
wherea
fap
enough
space
site
fap
partial
occupi
site
fig
present
structur
comparison
appli
describ
gliptin
sensit
though
crystal
structur
yet
report
known
inhibit
class
gliptin
vildagliptin
saxagliptin
activ
site
center
subsit
dpp
ivfamili
enzym
highli
conserv
figur
except
region
figur
hand
length
sequenc
around
site
less
conserv
expect
lower
sequenc
ident
dpp
iv
approxim
compar
fap
dpp
iv
approxim
therefor
lower
sensit
class
gliptin
like
due
structur
differ
around
site
fig
studi
present
crystal
structur
bacteri
dpp
iv
pmdap
iv
free
form
complex
dipeptid
well
nonpeptidyl
inhibitor
crystal
structur
analys
sitedirect
mutagenesi
studi
reveal
novel
substrat
recognit
mechan
possibl
common
smdap
ivtyp
bacteri
dpp
iv
observ
mammalian
dpp
iv
acylenzym
intermedi
observ
dipeptid
complex
pmdap
iv
wherea
tetrahedr
intermedi
report
oligopeptid
complex
mammalian
dpp
iv
differ
reflect
differ
structur
environ
activesit
arg
residu
mammalian
bacteri
enzym
anticip
present
structur
analys
support
design
specif
inhibitor
dpp
iv
pathogen
organ
periplasm
form
pmdap
iv
express
purifi
describ
gene
code
pmdap
iv
residu
clone
p
mexicana
genom
dna
librari
cultiv
plate
assay
base
dpp
iv
activ
hydrolysi
pmdap
iv
mutant
produc
periplasm
form
residu
due
translat
remov
signal
sequenc
residu
periplasm
form
pmdap
iv
compris
amino
acid
theoret
molecular
weight
theoret
isoelectr
point
e
coli
takara
bio
transform
harbour
fulllength
pmdap
iv
mutant
sequenc
insert
takara
bio
express
plasmid
use
produc
periplasm
form
pmdap
iv
cell
grown
x
yt
media
k
overproduct
pmdap
iv
perform
iptg
induct
final
concentr
mm
approxim
sixteen
hour
induct
cell
harvest
centrifug
x
g
cell
disrupt
use
bugbust
protein
extract
reagent
novagen
cell
extract
obtain
centrifug
x
g
min
pmdap
iv
cell
extract
purifi
use
ammonium
sulphat
precipit
hydrophob
column
chromatographi
use
hiprep
butyl
column
ge
healthcar
desalt
use
hiprep
desalt
column
ge
healthcar
final
subject
anionexchang
column
chromatographi
use
mono
q
gl
column
ge
healthcar
fraction
contain
pmdap
iv
pool
buffer
exchang
mm
trishcl
ph
concentr
mgml
use
vivaspin
concentr
ge
healthcar
protein
concentr
determin
use
bradford
assay
bovin
serum
albumin
standard
biorad
laboratori
column
chromatographi
purif
step
perform
k
k
respect
obtain
ligandfre
pmdap
iv
crystal
sampl
crystallis
use
hangingdrop
method
protein
solut
mgml
pmdap
iv
mm
trishcl
ph
mix
volum
reservoir
solut
vv
glycerol
mv
mm
me
ph
incub
k
drop
suspend
reservoir
solut
plate
crystal
pmdap
ivdipeptid
tripeptid
use
substrat
ntermin
dipeptid
observ
bound
product
inhibitor
complex
prepar
follow
lysprotyr
ileproil
diprotin
hydroxymethyl
cyclopentyl
amino
acetyl
purchas
bachem
ag
bubendorf
switzerland
peptid
institut
inc
osaka
japan
wako
pure
chemic
industri
ltd
osaka
japan
respect
tripeptid
lysprotyr
ileproil
inhibitor
dissolv
mm
trishcl
ph
concentr
mm
mm
mm
respect
pmdap
iv
solut
mix
aliquot
respect
ligand
solut
volum
ratio
tripeptid
lysprotyr
ileproil
inhibitor
respect
final
ligand
concentr
mm
mm
mm
respect
droplet
prepar
mix
equal
volum
work
solut
describ
reservoir
solut
contain
vv
glycerol
mv
mm
me
buffer
ph
tripeptid
complex
vv
glycerol
mv
mm
me
buffer
ph
inhibitor
complex
droplet
suspend
reservoir
solut
well
plate
crystallis
condit
ligandfre
dipeptideinhibitorbound
pmdap
iv
describ
includ
vv
glycerol
reservoir
solut
xray
data
could
collect
cryogen
condit
without
need
addit
cryoprotect
crystal
obtain
use
hangingdrop
method
directli
mount
nylon
loop
flashcool
cold
nitrogen
ga
stream
k
immedi
data
collect
data
collect
rotat
method
k
use
adsc
quantum
ccd
detector
detector
synchrotron
radiat
sourc
photon
factori
laue
group
unitcel
paramet
determin
use
xd
softwar
result
cell
paramet
datacollect
statist
summaris
tabl
initi
phase
determin
perform
use
molecular
replac
method
one
protom
smdap
pdb
code
search
model
crossrot
translat
function
calcul
use
programm
automat
model
build
refin
carri
use
program
iter
manual
model
build
refin
perform
use
program
stereochemistri
model
verifi
use
program
refin
structur
ligandfre
pmdap
iv
use
structur
determin
dipeptid
inhibitor
complex
differ
fourier
method
occup
ligand
atom
ligand
complex
estim
vari
occup
ligand
atom
set
increment
result
show
temperatur
factor
becam
closer
surround
atom
without
produc
posit
residu
peak
map
occup
ligand
atom
set
occup
result
posit
residu
peak
map
bound
ligand
atom
final
round
refin
ligand
molecul
atom
remov
model
amplitud
fc
phase
angl
calcul
partial
structur
use
calcul
weight
omit
figur
merit
approxim
equal
cosin
phase
error
estim
coordin
error
partial
structur
figur
refin
statist
summaris
tabl
pmdap
iv
involv
recognit
carbonyl
group
residu
substrat
peptid
mutat
ala
ly
mutant
express
purifi
use
method
describ
wildtyp
pmdap
iv
recombin
human
dpp
iv
purchas
atgen
co
ltd
lo
angel
usa
kinet
paramet
determin
fit
experiment
data
equat
use
excel
solver
microsoft
nonlinear
least
squar
fit
differ
concentr
glycyllprolin
glypromca
peptid
institut
substrat
enzym
reaction
perform
reaction
buffer
contain
mm
sodium
phosphat
buffer
ph
mm
edta
tween
k
min
standard
deviat
calcul
three
independ
experi
fluoresc
intens
releas
mca
measur
excit
nm
emiss
nm
use
infinit
pro
micropl
reader
tecan
rel
activ
wildtyp
mutant
pmdap
iv
human
dpp
iv
summaris
tabl
gliptin
diprotin
purchas
namiki
shoji
co
ltd
tokyo
japan
peptid
institut
inc
osaka
japan
respect
halfmaxim
inhibitori
concentr
valu
determin
fit
sigmoid
curv
logist
curv
use
competit
inhibit
rate
measur
use
differ
concentr
inhibitor
reaction
buffer
contain
mm
sodium
phosphat
buffer
ph
mm
edta
tween
k
min
use
glypromca
substrat
inhibitor
concentr
pmdap
iv
human
dpp
iv
nm
standard
deviat
calcul
three
independ
experi
fluoresc
intens
measur
excit
nm
emiss
nm
use
infinit
pro
micropl
reader
inhibit
constant
ki
calcul
use
chengprusoff
gliptin
sensit
diprotin
sensit
wildtyp
mutant
pmdap
iv
human
dpp
iv
summaris
tabl
respect
figur
produc
use
programm
ucsf
adob
illustr
adob
system
inc
san
jose
california
usa
figur
produc
use
adob
illustr
atom
coordin
report
structur
deposit
protein
data
bank
access
code
free
form
complex
ilepro
complex
lyspro
complex
